Previous 10 | Next 10 |
Recro Pharma ( REPH -40.6% ) Q1 results : More news on: Recro Pharma, Inc., Healthcare stocks news, Earnings news and commentary, Stocks on the move, , , Read more ...
Recro Pharma (NASDAQ: REPH ) -30% on Q1 earnings . More news on: Recro Pharma, Inc., ArcelorMittal, Vuzix Corporation, Stocks on the move, , Read more ...
Recro Pharma (NASDAQ: REPH ): Q1 GAAP EPS of -$0.33 misses by $0.30 . More news on: Recro Pharma, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
Company Generates $21.8 Million in First Quarter 2020 Revenues Revises Annual Revenue Guidance for 2020 MALVERN, Pa., May 11, 2020 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a leading contract development and manufacturing organization (CDMO), with integrated solutions f...
MALVERN, Pa., May 08, 2020 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (NASDAQ:REPH) a leading contract development and manufacturing organization (CDMO), with integrated solutions for the development, formulation, regulatory support, manufacturing and packaging of oral solid dose drug products,...
MALVERN, Pa., May 01, 2020 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (NASDAQ:REPH) (the “Company”), a high-performing, revenue generating contract development and manufacturing organization, today announced that due to the emerging health impact of the coronavirus pandemic, the C...
Gainers: Top Ships (NASDAQ: TOPS ) +111% . More news on: Top Ships Inc., Tetraphase Pharmaceuticals, Inc., Owens & Minor, Inc., Stocks on the move, , Read more ...
Original post Editor's Note: The summary bullets for this article were chosen by Seeking Alpha Read more ...
Originally posted on Reddit Editor's Note: The summary bullets for this article were chosen by Seeking Alpha Read more ...
Baudax Bio ( BXRX ) has slipped under my radar despite receiving shares after its spin-out from Recro Pharma ( REPH ) at the end of 2019. BXRX started trading back in November and is already preparing for a PDUFA for its lead product candidate Anjeso. I quickly scrambled to gather all the fu...
News, Short Squeeze, Breakout and More Instantly...
Societal CDMO to be Acquired by CoreRx, Inc. to Create an Enhanced CDMO with Broad Capabilities Spanning Early-Stage Formulation Development through Commercial Manufacturing and Packaging CoreRx to Commence a Tender Offer for all Outstanding Shares of Societal CDMO, Inc. CLEARWATE...
Agreement Broadly Applicable to All Therapeutic Areas with Specific Focus on the Growing Psychedelic and Cannabinoid Drug Development Markets Complementary Capabilities Range from API Manufacturing through Process Development and cGMP Manufacturing to Fill/Finish GAINESVILLE, Ga. ...
Recorded Q3 Revenue of $23.6 Million Signed Multiple New Business Agreements with New and Existing Customers Closed Public Offering Raising Gross Proceeds of Approximately $8.3 Million Initiated Corporate Restructuring; Expected to Result in Annualized Savings of Approxi...